Axsome Therapeutics (AXSM) Debt Ratio (2016 - 2026)

Axsome Therapeutics has reported Debt Ratio for 11 years, with the latest figure at 0.18 in Q1 2026.

• Quarterly Debt Ratio fell 43.22% year-over-year to 0.18 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.18 (down 43.22% YoY) and the FY2025 annual result came in at 0.19, down 41.73% from the prior year.
• Debt Ratio fell to 0.18 in Q1 2026 per AXSM's latest filing, from 0.19 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.56 in Q1 2022 and troughed at 0.16 in Q3 2024.
• A 5-year average of 0.31 and a median of 0.31 in 2023 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2022 and 2024: Debt Ratio surged 91.24% in 2022, then tumbled 48.77% in 2024.
• Over 5 years, Debt Ratio stood at 0.3 in 2022, then advanced by 3.79% to 0.31 in 2023, then rose by 1.36% to 0.32 in 2024, then plunged by 41.73% to 0.19 in 2025, then fell by 2.4% to 0.18 in 2026.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.18, 0.19, and 0.19 for Q1 2026, Q4 2025, and Q3 2025 respectively.